{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:49:56Z","timestamp":1782226196760,"version":"3.54.5"},"reference-count":20,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjtcs"],"DOI":"10.4274\/tjtcs.2026.28506","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T08:49:46Z","timestamp":1773650986000},"source":"Crossref","is-referenced-by-count":0,"title":["Factors affecting prognosis in patients diagnosed with epithelioid pleural mesothelioma who underwent surgery"],"prefix":"10.4274","author":[{"given":"Neslihan","family":"Akanil Fener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurcan","family":"\u00dcnver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halide Nur","family":"\u00dcrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysu Sinem","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u00e7ehre","family":"O\u011fuzt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekrem Cengiz","family":"Seyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celal Bu\u011fra","family":"Sezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Rosen LE, Karrison T, Ananthanarayanan V, Gallan AJ, Adusumilli PS, Alchami FS, et al. Nucle-ar grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a mul-ti-institutional study. Mod Pathol. 2018;31:598-606. doi: 10.1038\/modpathol.2017.170.","DOI":"10.1038\/modpathol.2017.170"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Kadota K, Suzuki K, Colovos C, Sima CS, Rusch VW, Travis WD, et al. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma. Mod Pathol. 2012;25:260-71. doi: 10.1038\/modpathol.2011.146.","DOI":"10.1038\/modpathol.2011.146"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. G\u00fcrb\u00fcz M, Utkan G. Management of malignant pleural mesothelioma. J Ankara Univ Fac Med. 2019;72:24-8. DOI: 10.4274\/atfm.galenos.2019.43153.","DOI":"10.4274\/atfm.galenos.2019.43153"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Forest F, Patoir A, Dal Col P, Sulaiman A, Camy F, Laville D, et al. Nuclear grading, BAP1, meso-thelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications. Pa-thology. 2018;50:635-41. doi: 10.1016\/j.pathol.2018.05.002.","DOI":"10.1016\/j.pathol.2018.05.002"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Habougit C, Trombert-Paviot B, Karpathiou G, Casteillo F, Bayle-Bleuez S, Fournel P, et al. His-topathologic features predict survival in diffuse pleural malignant mesothelioma on pleural bi-opsies. Virchows Arch. 2017;470:639-46. doi: 10.1007\/s00428-017-2109-z.","DOI":"10.1007\/s00428-017-2109-z"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Galateau-Salle F, Churg A, Roggli V, Travis WD; World Health Organization Committee for Tu-mors of the Pleura. The 2015 World Health Organization Classification of tumors of the pleura: advances since the 2004 classification. J Thorac Oncol. 2016;11:142-54. doi: 10.1016\/j.jtho.2015.11.005.","DOI":"10.1016\/j.jtho.2015.11.005"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Nicholson AG, Sauter JL, Nowak AK, Kindler HL, Gill RR, Remy-Jardin M, et al. EURACAN\/ IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. J Thorac Oncol. 2020;15:29-49. doi: 10.1016\/j.jtho.2019.08.2506.","DOI":"10.1016\/j.jtho.2019.08.2506"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Schulte JJ, Husain AN. Updates on grading mesothelioma. Histopathology. 2024;84:153-62. doi: 10.1111\/his.15065.","DOI":"10.1111\/his.15065"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Nakamura A, Takuwa T, Hashimoto M, Kuroda A, Nakamichi T, Matsumoto S, et al. Clinical outcomes with recurrence after pleurectomy\/decortication for malignant pleural mesothelio-ma. Ann Thorac Surg. 2020;109:1537-43. doi:https:\/\/doi.org\/10.1016\/j.athoracsur.2019.11.048.","DOI":"10.1016\/j.athoracsur.2019.11.048"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Bill\u00e9 A, Krug LM, Woo KM, Rusch VW, Zauderer MG. Contemporary analysis of prognostic fac-tors in patients with unresectable malignant pleural mesothelioma. J Thorac Oncol. 2016;11:249-55. doi:https:\/\/doi.org\/10.1016\/j.jtho.2015.10.003.","DOI":"10.1016\/j.jtho.2015.10.003"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, et al. Extrapleural pneumo-nectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135:620-6, 626.e1-3. doi: 10.1016\/j.jtcvs.2007.10.054.","DOI":"10.1016\/j.jtcvs.2007.10.054"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Montanaro F, Rosato R, Gangemi M, Roberti S, Ricceri F, Merler E, et al. Survival of pleural ma-lignant mesothelioma in Italy: a population-based study. Int J Cancer. 2009;124:201-7. doi:https:\/\/doi.org\/10.1002\/ijc.23874","DOI":"10.1002\/ijc.23874"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M, et al. Computed tomography fea-tures in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Ra-diol. 2002;41:1-9. doi: 10.1016\/s0720-048x(01)00426-0.","DOI":"10.1016\/S0720-048X(01)00426-0"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Nakazato Y, Minami Y, Kobayashi H, Satomi K, Anami Y, Tsuta K, et al. Nuclear grading of pri-mary pulmonary adenocarcinomas: correlation between nuclear size and prognosis. Cancer. 2010;116:2011-9. doi: 10.1002\/cncr.24948.","DOI":"10.1002\/cncr.24948"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Thomas JS, Kerr GR, Jack WJ, Campbell F, McKay L, Pedersen HC, et al. Histological grading of invasive breast carcinoma a simplification of existing methods in a large conservation series with long term follow-up. Histopathology. 2009;55:724-31. doi: https:\/\/ doi.org\/10.1111\/j.1365-2559.2009.03429.x.","DOI":"10.1111\/j.1365-2559.2009.03429.x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol. 2009;22:24-36. doi:doi.org\/10.1038\/modpathol.2008.183.","DOI":"10.1038\/modpathol.2008.183"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R, Haapasalo H. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with spe-cial reference to mitotic frequency. Int J Cancer. 1992;51:396-403. doi: 10.1002\/ijc.2910510311.","DOI":"10.1002\/ijc.2910510311"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Eckstein M, Matek C, Wagner P, Erber R, B\u00fcttner-Herold M, Wild PJ, et al. Proposal for a novel histological scoring system as a potential grading approach for muscle-invasive urothelial bladder cancer correlating with disease aggressiveness and patient outcomes. Eur Urol Oncol. 2024;7:128-38. doi: 10.1016\/j.euo.2023.07.011. Erratum in: Eur Urol Oncol. 2023;6:641. doi: 10.1016\/j.euo.2023.09.023.","DOI":"10.1016\/j.euo.2023.09.023"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Pelosi G, Papotti M, Righi L, Rossi G, Ferrero S, Bosari S, et al. Pathologic grading of malignant pleural mesothelioma: an evidence-based proposal. J Thorac Oncol. 2018;13:1750-61. doi:10.1016\/j.jtho.2018.07.002.","DOI":"10.1016\/j.jtho.2018.07.002"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Zhang YZ, Brambilla C, Molyneaux PL, Rice A, Robertus JL, Jordan S, et al. Presence of pleo-morphic features but not growth patterns improves prognostic stratification of epithelioid ma-lignant pleural mesothelioma by 2-tier nuclear grade. Histopathology. 2020;77:423-36. doi: 10.1111\/his.14127.","DOI":"10.1111\/his.14127"}],"container-title":["Turkish Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:53:10Z","timestamp":1782222790000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjtcvs.org\/articles\/factors-affecting-prognosis-in-patients-diagnosed-with-epithelioid-pleural-mesothelioma-who-underwent-surgery\/doi\/tjtcs.2026.28506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.4274\/tjtcs.2026.28506","relation":{},"ISSN":["1301-5680","1301-5680"],"issn-type":[{"value":"1301-5680","type":"print"},{"value":"1301-5680","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}